Company / CapEx per Share
Atea Pharmaceuticals, Inc. CapEx per Share History
FY2020-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.02
FY2022
5-year range
$0.00 / $0.02
FY2020-FY2022
Trend
+96271.7%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
CapEx per Share changed +96272% YoY in FY2022, a notable deviation from the 2-year average annual change of +48087%.
Based on SEC 10-K filings.
0.02 in FY2022.
Improved from $0.00 to $0.02 over the past 2 years.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, capex per share increased 96271.7% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 10.30 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $0.02 | +96271.7% |
| FY2021 | $0.00 | -98.0% |
| FY2020 | $0.00 | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026